In conclusion, the A1CF/FAM224A/miR-590-3p/ZNF143 positive feedback loop acts as a critical regulator in the malignant progression of glioma cells, providing a novel molecular target for glioma therapy. Here, ZNF143 is linked to central nervous system cancer.